BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 21331523)

  • 1. Pretransplant serum ferritin is associated with bloodstream infections within 100 days of allogeneic stem cell transplantation for myeloid malignancies.
    Tachibana T; Tanaka M; Takasaki H; Numata A; Ito S; Watanabe R; Hyo R; Ohshima R; Hagihara M; Sakai R; Fujisawa S; Tomita N; Fujita H; Maruta A; Ishigatsubo Y; Kanamori H
    Int J Hematol; 2011 Mar; 93(3):368-374. PubMed ID: 21331523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of pre-transplant serum ferritin on outcomes of patients with myelodysplastic syndromes or secondary acute myeloid leukaemia receiving reduced intensity conditioning allogeneic haematopoietic stem cell transplantation.
    Lim ZY; Fiaccadori V; Gandhi S; Hayden J; Kenyon M; Ireland R; Marsh J; Ho AY; Mufti GJ; Pagliuca A
    Leuk Res; 2010 Jun; 34(6):723-7. PubMed ID: 19944463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retrospective Evaluation of Relationship Between Iron Overload and Transplantation Complications in Pediatric Patient Who Underwent Allogeneic Stem Cell Transplantation Due to Acute Leukemia and Myelodysplastic Syndrome.
    Küpesiz FT; Hazar V; Eker N; Guler E; Yesilipek MA; Tuysuz G; Kupesiz A
    J Pediatr Hematol Oncol; 2020 Jul; 42(5):e315-e320. PubMed ID: 32427707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iron overload in patients with acute leukemia or MDS undergoing myeloablative stem cell transplantation.
    Armand P; Kim HT; Rhodes J; Sainvil MM; Cutler C; Ho VT; Koreth J; Alyea EP; Hearsey D; Neufeld EJ; Fleming MD; Steen H; Anderson D; Kwong RY; Soiffer RJ; Antin JH
    Biol Blood Marrow Transplant; 2011 Jun; 17(6):852-60. PubMed ID: 20854920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
    Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology of bloodstream infections after myeloablative and non-myeloablative allogeneic hematopoietic stem cell transplantation: A single-center cohort study.
    Gjaerde LI; Moser C; Sengeløv H
    Transpl Infect Dis; 2017 Oct; 19(5):. PubMed ID: 28561378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic value of serum C-reactive protein, ferritin, and albumin prior to allogeneic transplantation for acute myeloid leukemia and myelodysplastic syndromes.
    Artz AS; Logan B; Zhu X; Akpek G; Bufarull RM; Gupta V; Lazarus HM; Litzow M; Loren A; Majhail NS; Maziarz RT; McCarthy P; Popat U; Saber W; Spellman S; Ringden O; Wickrema A; Pasquini MC; Cooke KR;
    Haematologica; 2016 Nov; 101(11):1426-1433. PubMed ID: 27662010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicenter validation of scoring system of pre-transplant serum ferritin and disease risk in patients with acute myeloid leukemia and myelodysplastic syndrome after allogeneic hematopoietic stem cell transplant.
    Tachibana T; Tanaka M; Yamazaki E; Numata A; Takasaki H; Kuwabara H; Fujimaki K; Sakai R; Fujita H; Fujisawa S; Maruta A; Ishigatsubo Y; Kanamori H
    Leuk Lymphoma; 2013 Jun; 54(6):1318-20. PubMed ID: 22989327
    [No Abstract]   [Full Text] [Related]  

  • 9. Angiopoietin-2 predicts disease-free survival after allogeneic stem cell transplantation in patients with high-risk myeloid malignancies.
    Kümpers P; Koenecke C; Hecker H; Hellpap J; Horn R; Verhagen W; Buchholz S; Hertenstein B; Krauter J; Eder M; David S; Göhring G; Haller H; Ganser A
    Blood; 2008 Sep; 112(5):2139-48. PubMed ID: 18483397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum ferritin and disease status at transplantation predict the outcome of allo-SCT in patients with AML or myelodysplastic syndrome.
    Tachibana T; Takasaki H; Tanaka M; Maruta A; Hyo R; Ishigatsubo Y; Kanamori H
    Bone Marrow Transplant; 2011 Jan; 46(1):150-1. PubMed ID: 20383206
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical significance of pretransplant serum ferritin on the outcome of allogeneic hematopoietic SCT: a prospective cohort study by the Kanto Study Group for Cell Therapy.
    Tanaka M; Kanamori H; Matsumoto K; Tachibana T; Numata A; Ohashi K; Kobayashi T; Nakaseko C; Kanda Y; Yamazaki E; Fujisawa S; Ooi J; Sakura T; Aotsuka N; Onoda M; Machida S; Kato J; Usuki K; Watanabe R; Taguchi J; Yano S; Saito T; Takahashi S; Sakamaki H; Okamoto S;
    Bone Marrow Transplant; 2015 May; 50(5):727-33. PubMed ID: 25730191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iron overload in patients receiving allogeneic hematopoietic stem cell transplantation: quantification of iron burden by a superconducting quantum interference device (SQUID) and therapeutic effectiveness of phlebotomy.
    Busca A; Falda M; Manzini P; D'Antico S; Valfrè A; Locatelli F; Calabrese R; Chiappella A; D'Ardia S; Longo F; Piga A
    Biol Blood Marrow Transplant; 2010 Jan; 16(1):115-22. PubMed ID: 19766730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of pretransplant serum ferritin level on risk of invasive mold infection after allogeneic hematopoietic stem cell transplantation.
    Dadwal SS; Tegtmeier B; Liu X; Frankel P; Ito J; Forman SJ; Pullarkat V
    Eur J Haematol; 2015 Mar; 94(3):235-42. PubMed ID: 25082161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for pre- and post-engraftment bloodstream infections after allogeneic hematopoietic stem cell transplantation.
    Kikuchi M; Akahoshi Y; Nakano H; Ugai T; Wada H; Yamasaki R; Sakamoto K; Kawamura K; Ishihara Y; Sato M; Ashizawa M; Terasako-Saito K; Kimura S; Yamazaki R; Kanda J; Kako S; Nishida J; Kanda Y
    Transpl Infect Dis; 2015 Feb; 17(1):56-65. PubMed ID: 25580541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bloodstream Infection Due to Vancomycin-resistant Enterococcus Is Associated With Increased Mortality After Hematopoietic Cell Transplantation for Acute Leukemia and Myelodysplastic Syndrome: A Multicenter, Retrospective Cohort Study.
    Papanicolaou GA; Ustun C; Young JH; Chen M; Kim S; Woo Ahn K; Komanduri K; Lindemans C; Auletta JJ; Riches ML;
    Clin Infect Dis; 2019 Oct; 69(10):1771-1779. PubMed ID: 30649224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severity of acute gastrointestinal graft-vs-host disease is associated with incidence of bloodstream infection after adult allogeneic hematopoietic stem cell transplantation.
    Modi A; Rybicki L; Majhail NS; Mossad SB
    Transpl Infect Dis; 2020 Feb; 22(1):e13217. PubMed ID: 31769584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperferritinemia is associated with low incidence of graft versus host disease, high relapse rate, and impaired survival in patients with blood disorders receiving allogeneic hematopoietic stem cell grafts.
    Wahlin A; Lorenz F; Fredriksson M; Remberger M; Wahlin BE; Hägglund H
    Med Oncol; 2011 Jun; 28(2):552-8. PubMed ID: 20393815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantation.
    Armand P; Kim HT; Cutler CS; Ho VT; Koreth J; Alyea EP; Soiffer RJ; Antin JH
    Blood; 2007 May; 109(10):4586-8. PubMed ID: 17234738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of non-transferrin-bound iron (NTBI) in comparison to serum ferritin on outcome after allogeneic stem cell transplantation (ASCT).
    Hilken A; Langebrake C; Wolschke C; Kersten JF; Rohde H; Nielsen P; Kröger N
    Ann Hematol; 2017 Aug; 96(8):1379-1388. PubMed ID: 28585071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Red blood cell transfusion dependence and outcome after allogeneic peripheral blood stem cell transplantation in patients with de novo myelodysplastic syndrome (MDS).
    Platzbecker U; Bornhäuser M; Germing U; Stumpf J; Scott BL; Kröger N; Schwerdtfeger R; Böhm A; Kobbe G; Theuser C; Rabitsch W; Valent P; Sorror ML; Ehninger G; Deeg HJ
    Biol Blood Marrow Transplant; 2008 Nov; 14(11):1217-25. PubMed ID: 18940675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.